Showing promise in the field of obesity management, retatrutide presents a unique method. Different from many available medications, retatrutide works as a dual agonist, concurrently affecting both GLP peptide-1 (GLP-1) and glucose-responsive insulinotropic hormone (GIP) receptors. The dual stimulation encourages various helpful effects, including … Read More